Stable paclitaxel formulations in oily contrast medium

被引:22
作者
Lee, IH
Park, YT
Roh, K
Chung, H
Kwon, IC
Jeong, SY
机构
[1] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea
[2] Dae Hwa Pharmaceut Co Ltd, Seoul 150080, South Korea
关键词
paclitaxel; lipiodol; oily contrast medium; emulsion; cancer;
D O I
10.1016/j.jconrel.2004.10.023
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Stable paclitaxel/Lipiodol solutions as well as emulsions were developed for the treatment of solid tumors including hepatocellular carcinoma. Paclitaxel could be dissolved in Lipiodol, an oily contrast medium, but precipitated out and formed aggregates with time. Paclitaxel precipitation was due to the inter- and intra-molecular hydrogen bonding of paclitaxel molecules. Time-dependent paclitaxel aggregation was completely prevented by adding small amounts of additional solvents, which are miscible with Lipiodol. It was also notable that paclitaxel helped in stabilizing the water-in-oil (w/o) type emulsion of Lipiodol and lopamiro. The stability, physical properties and in vitro drug release profiles of the stable paclitaxel solutions and emulsions were characterized. When the stable oily paclitaxel solution was used for the treatment of B16F10 melanoma in C57BL/6 mice, the malignant cells were eradicated completely in 2 weeks, whereas the solid tumor grew rapidly and metastasized to the thigh and to other organs in the control group. Also, the mice survived for more than 1 year after the paclitaxel treatment, whereas all of those in the control group died in 40 days. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:415 / 425
页数:11
相关论文
共 30 条
[1]  
Arbuck SG, 1995, SEMIN ONCOL, V22, P55
[2]   SOLVENT-DEPENDENT AND CONCENTRATION-DEPENDENT MOLECULAR-INTERACTIONS OF TAXOL (PACLITAXEL) [J].
BALASUBRAMANIAN, SV ;
ALDERFER, JL ;
STRAUBINGER, RM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (10) :1470-1476
[3]   HEPATIC-ARTERY INJECTION OF I-131-LABELED LIPIODOL .2. PRELIMINARY-RESULTS OF THERAPEUTIC USE IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA AND LIVER METASTASES [J].
BRETAGNE, JF ;
RAOUL, JL ;
BOURGUET, P ;
DUVAUFERRIER, R ;
DEUGNIER, Y ;
FAROUX, R ;
RAMEE, A ;
HERRY, JY ;
GASTARD, J .
RADIOLOGY, 1988, 168 (02) :547-550
[4]   CONTROLLED DELIVERY OF TAXOL FROM MICROSPHERES COMPOSED OF A BLEND OF ETHYLENE-VINYL ACETATE COPOLYMER AND POLY (D,L-LACTIC ACID) [J].
BURT, HM ;
JACKSON, JK ;
BAINS, SK ;
LIGGINS, RT ;
OKTABA, AMC ;
ARSENAULT, AL ;
HUNTER, WL .
CANCER LETTERS, 1995, 88 (01) :73-79
[5]  
Dombernowsky P, 1995, SEMIN ONCOL, V22, P13
[6]  
DOSIO F, 2000, P INT S CONTR REL BI, V27, P6320
[7]   Antitumor activity of tributyrin in murine melanoma model [J].
Giermasz, A ;
Nowis, D ;
Jalili, A ;
Basak, G ;
Marczak, M ;
Makowski, M ;
Czajka, A ;
Mlynarczuk, I ;
Hoser, G ;
Stok, T ;
Lewandowski, S ;
Jakóbisiak, M .
CANCER LETTERS, 2001, 164 (02) :143-148
[8]  
Iwai K, 1984, CANCER RES, V44, P2114
[9]   Development of nonionic sulfactant/phospholipid o/w emulsion as a paclitaxel delivery system [J].
Kan, P ;
Chen, ZB ;
Lee, CJ ;
Chu, IM .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (03) :271-278
[10]   SELECTIVE EFFECTS OF LIPIODOLIZED ANTITUMOR AGENTS [J].
KANEMATSU, T ;
INOKUCHI, K ;
SUGIMACHI, K ;
FURUTA, T ;
SONODA, T ;
TAMURA, S ;
HASUO, K .
JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (03) :218-226